Nickson Philip 4
4 · Monte Rosa Therapeutics, Inc. · Filed Apr 10, 2026
Research Summary
AI-generated summary of this filing
Monte Rosa Therapeutics (GLUE) CBO Nickson Philip Sells Shares
What Happened
Nickson Philip, Chief Business & Legal Officer of Monte Rosa Therapeutics (GLUE), reported the sale of 5,845 shares on April 9, 2026. The reported weighted-average price was $17.69 per share for total proceeds of approximately $103,413. The filing lists the transaction type as an open‑market or private sale (Form 4 code S).
Key Details
- Transaction date: 2026-04-09; Form 4 filed: 2026-04-10 (timely filing).
- Shares sold: 5,845 at a weighted-average price of $17.69; total proceeds ~ $103,413.
- Price range reported in footnote: $17.6901 to $17.71 (sale executed in multiple transactions; detailed per‑price breakdown available on request per filer).
- Shares owned after the transaction: not specified in this Form 4.
- No 10b5-1 plan, tax withholding, or late filing indicated in this filing.
Context
This was a sale (not a purchase), which is often routine for insiders and does not by itself indicate company performance or insider sentiment. The filing provides a weighted average and a narrow price range, suggesting multiple small transactions on the same day.
Insider Transaction Report
Form 4
Nickson Philip
Chief Business & Legal Officer
Transactions
- Sale
Common Stock
[F1]2026-04-09$17.69/sh−5,845$103,413→ 55,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.6901 to $17.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Signature
/s/ Philip Nickson|2026-04-10